Taken together, these data demonstrated that ZEB1 is the direct target of miR-455-3p in CCA and the underlying mechanism of DMY mediated-EMT inhibition effects in CCA may be through regulating the miR-455-3p/ZEB1 axis. This evidence concerns the gene ZEB1 and cholangiocarcinoma.